BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:KQ-2003 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of KQ-2003\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06518876-3264@assetmemo.bio
DTSTAMP:20261121T005824Z
DTSTART;VALUE=DATE:20271231
DTEND;VALUE=DATE:20280101
SUMMARY:KQ-2003: Phase 1 readout est. (NCT06518876)
DESCRIPTION:KQ-2003\, phase 1.\nStudy: A Study of KQ-2003 CAR-T Cell Therap
 y for Patients With Relapsed or Refractory POEMS Syndrome\nEstimated prima
 ry completion: 31 December 2027. This is a ClinicalTrials.gov estimate\, n
 ot a confirmed readout date\, and it can move.\nDrug page: https://assetme
 mo.bio/drug/kq-2003#upcoming-events\nRegistry record: https://clinicaltria
 ls.gov/study/NCT06518876
URL:https://assetmemo.bio/drug/kq-2003#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
